BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16281077)

  • 1. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
    Ribeiro RC; Razzouk BI; Pounds S; Hijiya N; Pui CH; Rubnitz JE
    Leukemia; 2005 Dec; 19(12):2125-9. PubMed ID: 16281077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
    Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ
    Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials.
    Armendariz H; Barbieri MA; Freigeiro D; Lastiri F; Felice MS; Dibar E
    Leukemia; 2005 Dec; 19(12):2139-42. PubMed ID: 16304573
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
    Smith FO; Alonzo TA; Gerbing RB; Woods WG; Arceci RJ;
    Leukemia; 2005 Dec; 19(12):2054-62. PubMed ID: 16136168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
    Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ;
    Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.
    Dluzniewska A; Balwierz W; Armata J; Balcerska A; Chybicka A; Kowalczyk J; Matysiak M; Ochocka M; Radwanska U; Rokicka-Milewska R; Sonta-Jakimczyk D; Wachowiak J; Wysocki M
    Leukemia; 2005 Dec; 19(12):2117-24. PubMed ID: 16107894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.
    Kardos G; Zwaan CM; Kaspers GJ; de-Graaf SS; de Bont ES; Postma A; Bökkerink JP; Weening RS; van der Does-van den Berg A; van Wering ER; Korbijn C; Hählen K
    Leukemia; 2005 Dec; 19(12):2063-71. PubMed ID: 16107896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
    Creutzig U; Zimmermann M; Ritter J; Reinhardt D; Hermann J; Henze G; Jürgens H; Kabisch H; Reiter A; Riehm H; Gadner H; Schellong G
    Leukemia; 2005 Dec; 19(12):2030-42. PubMed ID: 16304570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.
    Pession A; Rondelli R; Basso G; Rizzari C; Testi AM; Fagioli F; De Stefano P; Locatelli F;
    Leukemia; 2005 Dec; 19(12):2043-53. PubMed ID: 16107897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved results in the treatment of acute myeloid leukemia - Results of study AML-BFM-93 in East Germany with comparisons to the preceding studies AML-I-82 and AML-II-87].
    Steinbach D; Dörffel W; Eggers G; Holfeld E; Kluba U; Krause I; Lauterbach I; Reiss T; Rieske K; Scharfe V; Schumacher R; Weigel H; Weinmann G; Zintl F; Hermann J
    Klin Padiatr; 2001; 213(4):162-8. PubMed ID: 11528549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
    Schlenk RF; Benner A; Hartmann F; del Valle F; Weber C; Pralle H; Fischer JT; Gunzer U; Pezzutto A; Weber W; Grimminger W; Preiss J; Hensel M; Fröhling S; Döhner K; Haas R; Döhner H;
    Leukemia; 2003 Aug; 17(8):1521-8. PubMed ID: 12886238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved treatment results for childhood acute myeloid leukemia in Taiwan.
    Liang DC; Chan TT; Lin KH; Lin DT; Lu MY; Chen SH; Liu HC; Lin MT; Lee MT; Shu SG; Chang TK; Chen JS; Hsiao CC; Hung IJ; Hsieh YL; Chen RL; Cheng SN; Chang WH; Lee CH; Lin KS
    Leukemia; 2006 Jan; 20(1):136-41. PubMed ID: 16281075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
    Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
    J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital.
    Rivera GK; Pinkel D; Simone JV; Hancock ML; Crist WM
    N Engl J Med; 1993 Oct; 329(18):1289-95. PubMed ID: 8413409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved treatment results in children with AML: Results of study AML-BFM 93].
    Creutzig U; Berthold F; Boos J; Fleischhack G; Gadner H; Gnekow A; Graubner U; Henze G; Hermann J; Imbach P; Jürgens H; Kabisch H; Körholz D; Niemeyer CM; Reinhardt D; Reiter A; Ritter J; Spaar HJ; Zimmermann M;
    Klin Padiatr; 2001; 213(4):175-85. PubMed ID: 11528551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
    Gamis AS; Woods WG; Alonzo TA; Buxton A; Lange B; Barnard DR; Gold S; Smith FO;
    J Clin Oncol; 2003 Sep; 21(18):3415-22. PubMed ID: 12885836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.